These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28603635)

  • 1. Clinical trial allocation in multinational pharmaceutical companies - a qualitative study on influential factors.
    Dombernowsky T; Haedersdal M; Lassen U; Thomsen SF
    Pharmacol Res Perspect; 2017 Jun; 5(3):e00317. PubMed ID: 28603635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations.
    Dombernowsky T; Haedersdal M; Lassen U; Thomsen SF
    Trials; 2019 Dec; 20(1):708. PubMed ID: 31829234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Asset exchange"-interactions between patient groups and pharmaceutical industry: Australian qualitative study.
    Parker L; Fabbri A; Grundy Q; Mintzes B; Bero L
    BMJ; 2019 Dec; 367():l6694. PubMed ID: 31831471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients.
    Cortegiani A; Russotto V; Maggiore A; Attanasio M; Naro AR; Raineri SM; Giarratano A
    Cochrane Database Syst Rev; 2016 Jan; 2016(1):CD004920. PubMed ID: 26772902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global talent management and multinational subsidiaries' resilience in the Covid-19 crisis: Moderating roles of regional headquarters' support and headquarters-subsidiary friction.
    Lee JY; Yahiaoui D; Lee KP; Cooke FL
    Hum Resour Manage; 2022; 61(3):355-372. PubMed ID: 35572808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Qualitative Interview Study on Expanded Access Clinical Trials for Compassionate Use in Japan.
    Hayashi H; Nogita T; Maeda H
    Patient Prefer Adherence; 2024; 18():1471-1479. PubMed ID: 39011090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key cost drivers of pharmaceutical clinical trials in the United States.
    Sertkaya A; Wong HH; Jessup A; Beleche T
    Clin Trials; 2016 Apr; 13(2):117-26. PubMed ID: 26908540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Characteristics of Clinical Studies Submitted to the Saudi Food and Drug Authority from 2009 until 2020.
    Aljawadi MH; Aldhahri RA; AlMetwazi MS; Arafah A; Khoja AT
    Saudi Pharm J; 2021 Oct; 29(10):1155-1165. PubMed ID: 34703369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Transparency in relations between multinational R&D pharmaceutical companies' corporate social responsibility activities and patient organizations in the Europe, Japan, and the United States].
    Kato M; Ishikawa H; Okuhara T; Kiuchi T
    Nihon Koshu Eisei Zasshi; 2019; 66(12):746-755. PubMed ID: 31875625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of Risk-Based Quality Management Status and Establishment of Operational Model in Clinical Trials.
    Kim E; Lim C
    Yonsei Med J; 2020 May; 61(5):423-430. PubMed ID: 32390366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea.
    Jeon J; Kim H; Yu KS
    J Korean Med Sci; 2020 Sep; 35(36):e329. PubMed ID: 32924344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of an end-to-end service solution to support lupus patients and improve their experience in clinical trials.
    Allen J; Child A; Mertens S
    Clin Trials; 2019 Feb; 16(1):71-80. PubMed ID: 30428691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Globalization of clinical trials: Variation in estimated regional costs of pivotal trials, 2015-2016.
    Qiao Y; Alexander GC; Moore TJ
    Clin Trials; 2019 Jun; 16(3):329-333. PubMed ID: 30922113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician Perceptions of the Use of Social Media for Recruitment of Patients in Cancer Clinical Trials.
    Sedrak MS; Sun V; Liu J; George K; Wong AR; Dale W; Dizon DS
    JAMA Netw Open; 2019 Sep; 2(9):e1911528. PubMed ID: 31532517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint recommendations for a total services account as a factor in simplifying contracts.
    Bruns I; Schade-Brittinger C; Wissing F; Ruppert T; Trillsch M
    Ger Med Sci; 2019; 17():Doc10. PubMed ID: 31728135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eliciting views of Australian pharmaceutical industry employees on collaboration and the concept of Quality Use of Medicines.
    Wang N; Lipworth WL; Ritchie JE; Williams KM; Day RO
    Intern Med J; 2011 Apr; 41(4):314-20. PubMed ID: 20403068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigator and site selection and performing GCP clinical studies in India.
    Maggon K
    Control Clin Trials; 2004 Aug; 25(4):366-77. PubMed ID: 15296811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirements for a Successful Drug Launch in Small Markets: A Pilot Study in Lebanon.
    Ramadan B; Metni M; Hamadeh G; Kurdi M; Karam R
    Value Health Reg Issues; 2019 Sep; 19():59-64. PubMed ID: 31078969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of endpoints in breast cancer clinical trials: a qualitative study of key trial stakeholders.
    Cui W; Phillips KA; Anderson RA; Francis PA; Loi S; Loibl S; Partridge AH; Keogh LA
    Am J Cancer Res; 2022; 12(12):5599-5612. PubMed ID: 36628283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing clinical grant costs.
    Glass HE; Hollander K
    Contemp Clin Trials; 2009 May; 30(3):221-6. PubMed ID: 19470309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.